SMTL ID : 1oz3.1

Crystal Structure of 3-MBT repeats of lethal (3) malignant Brain Tumor (Native-I) at 1.85 angstrom

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

homo-9-mer

Ligands

30 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: Y.79, S.80, H.83, K.111 Chain C: P.250 Ligand excluded by PLIP SO4.2: 4 residues within 4Å: Chain A: S.119, W.120, S.121, Q.122 Ligand excluded by PLIP SO4.5: 4 residues within 4Å: Chain B: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.6: 4 residues within 4Å: Chain B: H.286, D.288, G.289 Chain C: L.147 Ligand excluded by PLIP SO4.7: 3 residues within 4Å: Chain B: S.291, H.292 Chain C: K.246 Ligand excluded by PLIP SO4.8: 4 residues within 4Å: Chain B: P.25, V.26 Chain I: S.291, Y.294 Ligand excluded by PLIP SO4.9: 2 residues within 4Å: Chain B: K.284, W.297 Ligand excluded by PLIP SO4.12: 4 residues within 4Å: Chain C: H.286, D.288, G.289, W.290 Ligand excluded by PLIP SO4.13: 5 residues within 4Å: Chain C: E.101, S.119, W.120, S.121 Chain I: K.39 Ligand excluded by PLIP SO4.14: 3 residues within 4Å: Chain C: P.133, K.134, H.135 Ligand excluded by PLIP SO4.17: 5 residues within 4Å: Chain D: Y.79, S.80, H.83, K.111 Chain F: P.250 Ligand excluded by PLIP SO4.18: 4 residues within 4Å: Chain D: S.119, W.120, S.121, Q.122 Ligand excluded by PLIP SO4.21: 4 residues within 4Å: Chain E: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.22: 4 residues within 4Å: Chain E: H.286, D.288, G.289 Chain F: L.147 Ligand excluded by PLIP SO4.23: 3 residues within 4Å: Chain E: S.291, H.292 Chain F: K.246 Ligand excluded by PLIP SO4.24: 2 residues within 4Å: Chain E: P.25, V.26 Ligand excluded by PLIP SO4.25: 2 residues within 4Å: Chain E: K.284, W.297 Ligand excluded by PLIP SO4.28: 4 residues within 4Å: Chain F: H.286, D.288, G.289, W.290 Ligand excluded by PLIP SO4.29: 4 residues within 4Å: Chain F: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.30: 3 residues within 4Å: Chain F: P.133, K.134, H.135 Ligand excluded by PLIP SO4.33: 5 residues within 4Å: Chain G: Y.79, S.80, H.83, K.111 Chain I: P.250 Ligand excluded by PLIP SO4.34: 4 residues within 4Å: Chain G: S.119, W.120, S.121, Q.122 Ligand excluded by PLIP SO4.37: 4 residues within 4Å: Chain H: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.38: 4 residues within 4Å: Chain H: H.286, D.288, G.289 Chain I: L.147 Ligand excluded by PLIP SO4.39: 3 residues within 4Å: Chain H: S.291, H.292 Chain I: K.246 Ligand excluded by PLIP SO4.40: 4 residues within 4Å: Chain F: S.291, Y.294 Chain H: P.25, V.26 Ligand excluded by PLIP SO4.41: 2 residues within 4Å: Chain H: K.284, W.297 Ligand excluded by PLIP SO4.44: 4 residues within 4Å: Chain I: H.286, D.288, G.289, W.290 Ligand excluded by PLIP SO4.45: 5 residues within 4Å: Chain F: K.39 Chain I: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.46: 3 residues within 4Å: Chain I: P.133, K.134, H.135 Ligand excluded by PLIP

18 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.3: 5 residues within 4Å: Chain A: D.52, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.4: 7 residues within 4Å: Chain A: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.10: 5 residues within 4Å: Chain B: D.52, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.11: 7 residues within 4Å: Chain B: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.15: 7 residues within 4Å: Chain C: D.52, F.60, F.76, Y.79, S.80, H.83, K.111 Ligand excluded by PLIP MES.16: 7 residues within 4Å: Chain C: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.19: 5 residues within 4Å: Chain D: D.52, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.20: 7 residues within 4Å: Chain D: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.26: 5 residues within 4Å: Chain E: D.52, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.27: 7 residues within 4Å: Chain E: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.31: 7 residues within 4Å: Chain F: D.52, F.60, F.76, Y.79, S.80, H.83, K.111 Ligand excluded by PLIP MES.32: 7 residues within 4Å: Chain F: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.35: 5 residues within 4Å: Chain G: D.52, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.36: 7 residues within 4Å: Chain G: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.42: 5 residues within 4Å: Chain H: D.52, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.43: 7 residues within 4Å: Chain H: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.47: 7 residues within 4Å: Chain I: D.52, F.60, F.76, Y.79, S.80, H.83, K.111 Ligand excluded by PLIP MES.48: 7 residues within 4Å: Chain I: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, W.K. et al., Malignant brain tumor repeats: a three-leaved propeller architecture with ligand/peptide binding pockets. Structure (2003)

Release Date

2003-08-19

Peptides

Lethal(3)malignant brain tumor-like protein: ABCDEFGHI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
A

E
B

F
C

G
A

H
B

I
C

Lethal(3)malignant brain tumor-like protein

Related Entries With Identical Sequence